News | January 12, 2005

Biophan To Demonstrate New Ceramic Motors For Medical Device Applications At Major Industry Conference

Biophan Technologies, Inc. (OTCBB: BIPH), a developer of next-generation biomedical technology, will demonstrate its proprietary ceramic motors for use in a wide range of medical and life science devices at the Medical Design and Manufacturing West (MD&M West) conference, January 10-12, at the Anaheim Convention Center in Anaheim, California. The announcement was made by Michael Weiner, CEO of Biophan. Biophan is the exclusive worldwide distributor for medical applications of the SQUIGGLE(TM) ceramic motor, produced by New Scale Technologies.

The MD&M West conference, organized by Canon Communications, LLC, is one of the world's largest meetings for medical device designers and manufacturers. It is being attended by thousands of key designers, decision-makers, and medical device industry executives from the United States, Europe, and Asia.

Biophan is showcasing innovative solutions based on its patent-pending direct linear drive motor constructed of advanced ceramic materials. The motor's unique, high-precision design involves only four parts--compared with hundreds for previously available products--that affords exceptionally high levels of dependability and performance. The SQUIGGLE motor offers a new positioning solution and can be easily scaled to fit a variety of sizes and advanced biomedical devices, including implantable drug delivery devices such as insulin pumps and implantable drug pumps, as well as precision dosage metering and microfluidic devices.

"The piezoelectric ceramic technology we have perfected allows the SQUIGGLE motor to be manufactured in a wide range of sizes and configurations, especially at very small sizes and low power," explained David Henderson, President of New Scale Technologies and inventor of this motor. "Our technology provides substantial advantages over other available biomedical motors. These advantages, such as safety and compatibility with Magnetic Resonance Imaging (MRI), have the potential to significantly improve the options available to the health care and bioscience industries."

Additional technical features of the SQUIGGLE ultrasonic motor includes nanometer precision, zero magnetic fields, no ferromagnetic materials, ultra-low outgassing, negligible heating, quiet movement, and consistent operation over a wide temperature range. The SQUIGGLE motors have been demonstrated from room temperature to 100 degrees Kelvin--or some 173 degrees below the freezing point of water. NASA's Goddard Space Flight Center is evaluating the ceramic motor technology for use at 4 degrees Kelvin--nearly absolute zero--for space applications.

Biophan will also highlight other advanced technologies at the MD&M West conference, including technologies for enabling interventional surgical devices or implants to be made MRI-safe and compatible. These technologies are being developed to enable a new generation of MRI-guided surgical procedures. The Company will also feature its recently announced patented anti-antenna technology for improving the safety of medical implants under MRI.

"We're very excited about highlighting our ceramic motor designs as well as our other recent achievements in development of medical device solutions," said Mr. Weiner. "Biophan is at the forefront of research and development of the next generation of biomedical devices, and our proprietary technologies advance the capabilities of devices across a wide spectrum of diagnostic and therapeutic procedures."

Biophan will be working with the medical device engineering community to use the Company's innovative ceramic motor and its MRI safety and imageability technologies to enable a range of new health-care and life-enhancing products.